These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2264951)

  • 1. Spasticity in spinal cord injured persons: quantitative effects of baclofen and placebo treatments.
    Hinderer SR; Lehmann JF; Price R; White O; deLateur BJ; Deitz J
    Am J Phys Med Rehabil; 1990 Dec; 69(6):311-7. PubMed ID: 2264951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The supraspinal anxiolytic effect of baclofen for spasticity reduction.
    Hinderer SR
    Am J Phys Med Rehabil; 1990 Oct; 69(5):254-8. PubMed ID: 2222986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal baclofen and the H-reflex.
    Macdonell RA; Talalla A; Swash M; Grundy D
    J Neurol Neurosurg Psychiatry; 1989 Sep; 52(9):1110-2. PubMed ID: 2795085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal baclofen for severe spasticity secondary to spinal cord injury.
    Lewis KS; Mueller WM
    Ann Pharmacother; 1993 Jun; 27(6):767-74. PubMed ID: 8329801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury.
    Loubser PG; Narayan RK; Sandin KJ; Donovan WH; Russell KD
    Paraplegia; 1991 Jan; 29(1):48-64. PubMed ID: 2023770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety study of arbaclofen placarbil in patients with spasticity due to spinal cord injury.
    Nance PW; Huff FJ; Martinez-Arizala A; Ayyoub Z; Chen D; Bian A; Stamler D
    Spinal Cord; 2011 Sep; 49(9):974-80. PubMed ID: 21577221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A benefit-risk assessment of baclofen in severe spinal spasticity.
    Dario A; Tomei G
    Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spasticity and the use of intrathecal baclofen in patients with spinal cord injury.
    Khurana SR; Garg DS
    Phys Med Rehabil Clin N Am; 2014 Aug; 25(3):655-69, ix. PubMed ID: 25064793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Botulinum Toxin Type A in Spasticity Caused by Spinal Cord Injury: A Randomized, Controlled Trial.
    Yan X; Lan J; Liu Y; Miao J
    Med Sci Monit; 2018 Nov; 24():8160-8171. PubMed ID: 30423587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.
    Van Schaeybroeck P; Nuttin B; Lagae L; Schrijvers E; Borghgraef C; Feys P
    Neurosurgery; 2000 Mar; 46(3):603-9; discussion 609-12. PubMed ID: 10719857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing spasticity in spinal cord injury: safe administration of bridge boluses during intrathecal baclofen pump refills.
    Elovic E; Kirshblum SC
    J Spinal Cord Med; 2003; 26(1):2-4. PubMed ID: 12830961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal baclofen for treatment of intractable spinal spasticity.
    Abel NA; Smith RA
    Arch Phys Med Rehabil; 1994 Jan; 75(1):54-8. PubMed ID: 8291963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intrathecal infusion of baclofen in patients with spasticity caused by spinal cord injuries.
    Korenkov AI; Niendorf WR; Darwish N; Glaeser E; Gaab MR
    Neurosurg Rev; 2002 Aug; 25(4):228-30. PubMed ID: 12172730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.
    Coffey JR; Cahill D; Steers W; Park TS; Ordia J; Meythaler J; Herman R; Shetter AG; Levy R; Gill B
    J Neurosurg; 1993 Feb; 78(2):226-32. PubMed ID: 8421205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of the effects of an alpha-2 adrenergic agonist on reflex properties in spinal cord injury using a system identification technique.
    Mirbagheri MM; Chen D; Rymer WZ
    J Neuroeng Rehabil; 2010 Jun; 7():29. PubMed ID: 20573252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic baclofen use on active movement in an individual with a spinal cord injury.
    Angeli C; Ochsner J; Harkema S
    Spinal Cord; 2012 Dec; 50(12):925-7. PubMed ID: 22945743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance--a case report and review of literature.
    Soni BM; Mani RM; Oo T; Vaidyanathan S
    Spinal Cord; 2003 Oct; 41(10):586-9. PubMed ID: 14504619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal baclofen: does tolerance occur?
    Akman MN; Loubser PG; Donovan WH; O'Neill ME; Rossi CD
    Paraplegia; 1993 Aug; 31(8):516-20. PubMed ID: 8414636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intrathecal baclofen on lumbosacral and cortical somatosensory evoked potentials.
    Kofler M; Donovan WH; Loubser PG; Berić A
    Neurology; 1992 Apr; 42(4):864-8. PubMed ID: 1565243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.